MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00270-022-03073-7

Медицинская библиотека · Cardiovascular and interventional radiology · 2022

Cost-Effectiveness of Drug-Coated Balloon Angioplasty Versus Conventional Balloon Angioplasty for Treating Below-the-Knee Arteries in Chronic Limb-Threatening Ischemia: The SINGA-PACLI Trial.

Sivapragasam Nirmali, Matchar David B, Zhuang Kun Da, Patel Ankur, Pua Uei, Win Hlaing Hlaing, Chandramohan Sivanathan, Venkatanarasimha Nanda, Chua Jasmine M E, Tan Glenn Wei Leong, Irani Farah G, Leong Sum, Tay Kiang Hiong, Chong Tze Tec, Tan Bien Soo

Рандомизированное исследованиеСтатьяПеревод в очереди

Аннотация

PURPOSE: Drug-coated balloon angioplasty (DCBA) has been studied as a potentially superior option compared to conventional percutaneous transluminal angioplasty (PTA) in treating below-the-knee (BTK) arteries in chronic limb-threatening ischemia (CLTI). The aim of this study is to examine the cost-effectiveness of DCBA versus PTA in BTK arteries based on a randomized controlled trial.

MATERIAL AND

METHODS

A prospective economic study was embedded in a randomized controlled trial of 138 patients with CLTI. Resource use and health outcomes were assessed at baseline, and at 3, 6 and 12 months post-intervention. Costs were calculated from a societal perspective and health outcomes measured using quality-adjusted life years with probabilistic sensitivity analysis performed to account for subject heterogeneity.

RESULTS

Compared with participants randomized to receive PTA, participants randomized to DCBA gained an average baseline-adjusted quality-adjusted life years (QALYs) of .012 while average total costs were USD$1854 higher; this translates to an incremental cost-effectiveness ratio (ICER) of US$154,500 additional cost per QALY gained. However, the estimate of ICER had substantial variance with only 48% of bootstrap ICERs meeting a benchmark threshold of US$57,705 (the average gross domestic product (GDP) per capita of Singapore).

CONCLUSION

The use of DCBA in BTK arteries in CLTI patients was not cost-effective compared with PTA.

LEVEL OF EVIDENCE: 2, Randomized trial.

Для цитирования: Sivapragasam Nirmali, Matchar David B, Zhuang Kun Da, Patel Ankur, Pua Uei, Win Hlaing Hlaing, Chandramohan Sivanathan, Venkatanarasimha Nanda, Chua Jasmine M E, Tan Glenn Wei Leong, Irani Farah G, Leong Sum, Tay Kiang Hiong, Chong Tze Tec, Tan Bien Soo. Cost-Effectiveness of Drug-Coated Balloon Angioplasty Versus Conventional Balloon Angioplasty for Treating Below-the-Knee Arteries in Chronic Limb-Threatening Ischemia: The SINGA-PACLI Trial.. Cardiovascular and interventional radiology. 2022. DOI: 10.1007/s00270-022-03073-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.